For in vitro diagnostic use as an indicator of human bone resorption. This test may be used as an aid in monitoring bone resorption changes of antiresorptive therapies in postmenopausal women, individuals with osteopenia, and in predicting skeletal response (bone mineral density) in postmenopausal women undergoing antiresorptive therapies.
Biotin, commonly found in hair, skin and nail supplements and multivitamins, may interfere with assay. Patients should be cautioned to stop biotin consumption at least 72 hours prior to sample collection.
Immediately following collection, thoroughly mix sample by gently inverting 5 times
Frozen (preferred) - 3 months
Freeze/thaw cycles - stable x6
Refrigerated - 2 days
Ambient - 6 hours
Electrochemiluminescence immunoassay (ECLIA)
Male: 38 - 724 pg/mL
Female:
Premenopausal: 34 - 635 pg/mL
Postmenopausal: 34 - 1037 pg/mL